Goldman Sachs Cuts Numbers on WebMD (WBMD), Says Outlook Still Uncertain
Tweet
Share
E-mailGet Alerts WBMD Hot Sheet
Price: $66.48 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Goldman Sachs reiterated its Sell rating and cut its price target on WebMD Health Corp. (NASDAQ: WBMD) from $23 to $22 following Q1 results, with revenues and adjusted EBITDA in line, and non-GAAP EPS of $0.16.
The firm said continued weakness is expected through Q2, though management sees improving in Q4 based on new drug introductions.
"We continue to believe that the weak pharma advertising environment, competition-driven pricing pressures, uncertainty around the CEO search and the transition to mobile, suggest an unfavorable risk/reward scenario for WebMD," the analyst aid.
The firm maintained FY12 EPS at $0.09, cut FY13 from $0.33 to $0.27 and cut FY14 from $0.48 to $0.43.
For an analyst ratings summary and ratings history on WebMD Health Corp. click here. For more ratings news on WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $22.75 yesterday.
The firm said continued weakness is expected through Q2, though management sees improving in Q4 based on new drug introductions.
"We continue to believe that the weak pharma advertising environment, competition-driven pricing pressures, uncertainty around the CEO search and the transition to mobile, suggest an unfavorable risk/reward scenario for WebMD," the analyst aid.
The firm maintained FY12 EPS at $0.09, cut FY13 from $0.33 to $0.27 and cut FY14 from $0.48 to $0.43.
For an analyst ratings summary and ratings history on WebMD Health Corp. click here. For more ratings news on WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $22.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amer Sports Inc. (AS) PT Lowered to $42 at Truist, but 'Momentum continues to surge in a tough macro'
- Centrus Energy Corp. (LEU) PT Raised to $185 at UBS
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
